The UFC announced on Monday afternoon that UFC lightweight Gilbert Melendez tested positive for exogenous origin of testosterone metabolites following his bout at UFC 188 in Mexico City on June 13 with Eddie Alvarez. A fight that he lost by split decision.
Melendez is currently on a two-fight losing streak. He’s been a pro since 2002 and in his last six bouts, he’s 3-3.
Melendez was scheduled to fight Al Iaquinta at UFC Fight Night 71 on July 15th, but that bout is now off due to the failed drug test.
The UFC issued the following on Monday:
Following his bout at UFC 188 in Mexico City on June 13, UFC lightweight Gilbert Melendez tested positive for exogenous origin of testosterone metabolites. The UFC has a strict, consistent policy against the use of any illegal and/or performance enhancing drugs, stimulants or masking agents by our athletes. As a result of the positive test, Melendez has accepted a one-year suspension, effective from the date of the bout, for violating the UFC Fighter Conduct Policy and Promotional Agreement with Zuffa, LLC.
“Regrettably, I tested positive in my post fight urine sample for UFC 188,” Melendez said. “I did not inject anything, but I am responsible and accept the consequences for the results. I will make sure I am better educated about the products I use and their implications. Going forward I will ensure no products I use will contain banned substances. I am sincerely apologetic to everyone who supports me, including my fans, sponsors and the UFC. I value your trust and respect and will do everything in my power to keep it.”
Melendez will no longer compete as scheduled on July 15. UFC officials are currently seeking a new opponent for Al Iaquinta, who was scheduled to face Melendez.
